Category: Disclosures

[Disclosure] SK hynix (000660 / SKHY) – Notice of Reference Price for Interim (Quarterly) Ex-Dividend / 2025-05-28

May 28, 2025August 11, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DARTMarket: KOSPI (000660) 💡 3-Second Summary The reference price for SK hynix common stock due to quarterly ex-dividend was announced as KRW 208,000 (no change in reference price), effective May 29, 2025. 📊 [Key Disclosure Content & Key Figures Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Ex-Dividend Implementation and…

Semiconductors, Disclosures

[Disclosure] Samsung Biologics (207940) – Investor Relations (IR) Holding Notice / 2025-05-28

May 28, 2025August 7, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has issued an advance notice announcing that it will hold an online Investor Relations (IR) conference for retail shareholders on May 29, 2025, at 4:30 PM KST to present key matters regarding its corporate spin-off (demerger) and conduct a Q&A session. 📊 [Key Disclosure…

Disclosures, Bio & Healthcare

[Disclosure] Hyundai Motor (005380) – Reference Price for Interim (Quarterly) Ex-Dividend / 2025-05-28

May 28, 2025August 12, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary The reference price for Hyundai Motor common stock on the interim (quarterly) ex-dividend date (May 29, 2025) has been set at KRW 185,900, with no change to the reference price. 📊 [Key Disclosure Contents & Major Figures Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification…

Disclosures, Automotive

[Disclosure] Hyundai Motor (005380) – Reference Price for Interim (Quarterly) Ex-Dividend (Hyundai Motor 2PB) / 2025-05-28

May 28, 2025August 12, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary The reference price for Hyundai Motor 2nd Preferred Stock B (Hyundai Motor 2PB) on the interim (quarterly) ex-dividend date (May 29, 2025) has been set at KRW 149,100, with no change to the reference price. 📊 [Key Disclosure Contents & Major Figures Summary] 📝 Editor’s Comment…

Disclosures, Automotive

[Disclosure] Hyundai Motor (005380) – Reference Price for Interim (Quarterly) Ex-Dividend (Hyundai Motor Preferred Stock) / 2025-05-28

May 28, 2025August 12, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary The reference price for Hyundai Motor 1st Preferred Stock (Hyundai Motor Preferred Stock) on the interim (quarterly) ex-dividend date (May 29, 2025) has been set at KRW 147,700, with no change to the reference price. 📊 [Key Disclosure Contents & Major Figures Summary] 📝 Editor’s Comment…

Disclosures, Automotive

[Disclosure] Hyundai Motor (005380) – Reference Price for Interim (Quarterly) Ex-Dividend (Hyundai Motor 3PB) / 2025-05-28

May 28, 2025August 12, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary The reference price for Hyundai Motor 3rd Preferred Stock B (Hyundai Motor 3PB) on the interim (quarterly) ex-dividend date (May 29, 2025) has been set at KRW 148,100, with no change to the reference price. 📊 [Key Disclosure Contents & Major Figures Summary] 📝 Editor’s Comment…

Disclosures, Automotive

[Disclosure] Celltrion (068270) – Modification of Listing (Share Cancellation) / 2025-05-27

May 27, 2025August 6, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion is modifying its stock listing on May 30, 2025, to reflect the cancellation of 589,276 common shares, reducing total issued shares to 222,425,958 shares. 📊 [Key Disclosure Details & Financial Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Listing Modification Execution on Scheduled…

Disclosures, Bio & Healthcare

[Disclosure] Celltrion (068270) – Decision on Bonus Issue / 2025-05-26

May 26, 2025August 6, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion has decided on a bonus issue of 0.04 new common share per 1 existing common share, issuing 8,477,626 new shares with a scheduled listing date of July 25, 2025. 📊 [Key Disclosure Details & Financial Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of…

Disclosures, Bio & Healthcare

[Disclosure] Samsung Biologics (207940) – Single Sales and Supply Contract / 2025-05-26

May 26, 2025August 7, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has disclosed the signing of a pharmaceutical contract manufacturing agreement with an Asian pharmaceutical company valued at approx. KRW 198.5B (USD 144,028,170), representing 4.37% of its FY2024 consolidated revenue. 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Monitoring…

Disclosures, Bio & Healthcare

[Disclosure] Samsung Biologics (207940) – Single Sales and Supply Contract / 2025-05-26

May 26, 2025August 7, 2026 K-STOCK Editor

Disclosures, Bio & Healthcare